LeonaBio (LONA) Profit After Tax (2019 - 2026)
LeonaBio (LONA) reported Profit After Tax of -$32.9 million for Q1 2026, down 259.84% year-over-year from $20.6 million in Q1 2025, and up 60.32% on a QoQ basis from -$82.9 million in Q4 2025.
LeonaBio (LONA) has 8 years of Profit After Tax data on file, last reported at -$32.9 million in Q1 2026.
- Quarterly Profit After Tax fell 259.84% year-over-year to -$32.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$129.4 million (down 62.25% YoY) and the FY2025 annual result came in at -$105.6 million, down 8.94% from the prior year.
- Profit After Tax advanced to -$32.9 million in Q1 2026 per LONA's latest filing, from -$82.9 million in the prior quarter.
- Across five years, Profit After Tax topped out at -$6.6 million in Q3 2025 and bottomed at -$82.9 million in Q4 2025.
- The 5-year median for Profit After Tax is -$26.9 million (2024), against an average of -$26.4 million.
- Peak annual rise in Profit After Tax reached 77.0% in 2025, while the deepest fall reached 452.62% in 2025.
- Tracing LONA's Profit After Tax over 5 years: stood at -$30.1 million in 2022, then grew by 9.46% to -$27.3 million in 2023, then surged by 45.01% to -$15.0 million in 2024, then plunged by 452.62% to -$82.9 million in 2025, then soared by 60.32% to -$32.9 million in 2026.
- Per Business Quant, the three latest LONA Profit After Tax figures stand at -$32.9 million (Q1 2026), -$82.9 million (Q4 2025), and -$6.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 30.90 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -3.63 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 727.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 205.99 Mn |
| 10 | LeonaBio | 181.52 Mn | 113.84 Mn | - | -32.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.90 Mn |
| Dec 31, 2025 | -82.91 Mn |
| Sep 30, 2025 | -6.61 Mn |
| Jun 30, 2025 | -6.97 Mn |
| Mar 31, 2025 | -9.14 Mn |
| Dec 31, 2024 | -15.00 Mn |
| Sep 30, 2024 | -28.74 Mn |
| Jun 30, 2024 | -26.86 Mn |
| Mar 31, 2024 | -26.34 Mn |
| Dec 31, 2023 | -27.29 Mn |
| Sep 30, 2023 | -32.97 Mn |
| Jun 30, 2023 | -29.60 Mn |
| Mar 31, 2023 | -27.82 Mn |
| Dec 31, 2022 | -30.14 Mn |
| Sep 30, 2022 | -20.19 Mn |
| Jun 30, 2022 | -24.34 Mn |
| Mar 31, 2022 | -20.98 Mn |
| Dec 31, 2021 | -16.34 Mn |
| Sep 30, 2021 | -15.67 Mn |
| Jun 30, 2021 | -13.97 Mn |
| Mar 31, 2021 | -8.87 Mn |
| Dec 31, 2020 | -7.70 Mn |
| Sep 30, 2020 | -8.46 Mn |
| Jun 30, 2020 | -1.99 Mn |
| Mar 31, 2020 | -1.81 Mn |
| Dec 31, 2019 | -974,000.00 |
| Sep 30, 2019 | -1.53 Mn |